Skip to content
Disclosery

13F-HR filed by Catalio Capital Management, LP

Catalio Capital Management, LP filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 38 holding rows worth $540,929,537.

Accession
0001958125-25-000009
Filer
CIK 1958125
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 38 entries on the cover page, a total value of $540,929,537 stated on the cover page (in dollars after the unit check, H1), rows summing to $540,929,537 with VALUE read as dollars as filed, 13F file number 028-25237. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Eli Lilly and Company532457108COM57,376$43,777,888dollars as filed
AbbVie,Inc.00287Y109COM154,834$35,850,264dollars as filed
BRIDGEBIO PHARMA INC10806X102COM622,729$32,344,544dollars as filed
Intuitive Surgical,Inc.46120E602COM71,343$31,906,730dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR144,954$28,818,305dollars as filed
SOLENO THERAPEUTICS INC834203309COM418,245$28,273,362dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM667,615$26,270,650dollars as filed
Boston Scientific Corporation101137107COM262,972$25,673,956dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM1,614,717$24,842,421dollars as filed
CYTOKINETICS INC23282W605COM NEW451,581$24,818,892dollars as filed
NATERA INC COM632307104Stock148,369$23,882,958dollars as filed
REGENERON PHARMACEUTICALS COM75886F107Stock35,344$19,872,871dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY651,810$18,250,680dollars as filed
UNIQURE NVN90064101SHS282,940$16,515,208dollars as filed
DISC MEDICINE INC COM254604101Stock216,527$14,308,104dollars as filed
ABIVAX SA-00370M103SPONSORED ADS162,141$13,765,771dollars as filed
SUPERNUS PHARMACEUTICALS868459108COM287,090$13,720,031dollars as filed
EXACT SCIENCES CORP COM30063P105Stock248,987$13,622,079dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK1,128,521$13,282,692dollars as filed
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock884,890$13,237,954dollars as filed
AVIDITY BIOSCIENCES INC COM05370A108Stock263,256$11,470,064dollars as filed
ADMA BIOLOGICS INC000899104COM684,508$10,034,887dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM291,262$8,761,161dollars as filed
FRACTYL HEALTH INC35168W103COM5,214,236$8,290,635dollars as filed
GRAIL INC384747101COM137,928$8,155,683dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK1,500,793$6,528,450dollars as filed
SEPTERNA INC COM81734D104Stock294,360$5,536,912dollars as filed
CIDARA THERAPEUTICS INC171757206COM NEW53,333$5,107,168dollars as filed
KYVERNA THERAPEUTICS INC501976104COMMON STOCK586,909$3,521,454dollars as filed
ELEDON PHARMACEUTICALS INC28617k101COM1,061,132$2,748,332dollars as filed
OUTSET MED INC690145206COM NEW118,279$1,670,099dollars as filed
METAGENOMI THERAPEUTICS INC59102M104COM528,993$1,253,713dollars as filed
ATAIBECKLEY INCN0731H103Equity196,858$1,041,379dollars as filed
HYPERFINE INC44916K106Common Stock684,541$992,584dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock133,131$954,549dollars as filed
KARYOPHARM THERAPEUTICS INC48576U205COMMON STOCK142,984$935,115dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK12,010$752,907dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW14,718$139,085dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001958125-25-000009this filing2025-11-14acceptance time not in the bulk data set